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Abstract 
AIM: This study aimed to evaluate a new modality of low power laser biostimulation in rat ovaries, in comparison 
with the conventional medical therapy by clomiphene citrate that depends on up-regulation of the hypothalamic-
pituitary-ovarian axis to induce ovulation.  
STUDY DESIGN: A Prospective experimental study carried out from January 2014 to February 2016.  
SETTING: University-based photobiology laboratory. 
MATERIALS AND METHODS: Seventy-two (72) Female-Wistar Albino rats were used in this study, divided into 
three groups: 17 rats used as a control group, 19 rats received clomiphene citrate (Clomid group), 36 rats 
exposed to diode laser 660 nm wavelength (laser group).  
RESULTS: Biochemical assessment of serum Estradiol and serum Progesterone was done in the three study 
groups. Serum Estradiol & Progesterone levels were statistically significantly higher in clomiphene and laser 
treated groups than non-interventional controls, while no significant difference between clomiphene and laser 
groups as regard of both hormones. 
CONCLUSION: This study shows that ovarian laser biostimulation is a new encouraging method for induction of 
ovulation, at least in animals. This had been proven biochemically by a significant increase in serum Estradiol and 
serum Progesterone. 
 
 
 
 
 
 
 
 
Introduction 
 
In humans as well as animals including rats, 
the reproductive function of the ovaries is controlled 
through complex feedback mechanisms, involving 
releasing factors from the hypothalamus and FSH and 
LH from pituitary gland. The resulting estrogen and 
progesterone produced by the ovarian follicles and 
corpora lutea, respectively, are the basis for the 
oestrous and menstrual cycles and also for normal 
reproductive function [1]. Many differences exist 
between menstrual and oestrous cycles, in humans, 
the reproductive cycle, called the menstrual cycle, last 
approximately 28 days, in rodents this cycle, called 
the oestrous cycle, lasts approximately 4-5 days. Rats 
display, most of the time, regular cycles; they are easy 
to manipulate, and the cycle is not disturbed easily 
even with the routine stress in the animal facility [2]. 
Another difference is that animals that have oestrous 
cycles reabsorb the endometrium if conception does 
not occur during that cycle. Animals that have 
menstrual cycles shed the endometrium through 
menstruation instead [3]. 
The estrus cycle is characterised as 
proestrus, estrus, metestrus (or diestrus I) and 
diestrus (or diestrus II) [4]. Vaginal smear cytology is 
used for the determination of the estrus cycle phases 
[5]. The characterisation of each phase is based on 
the proportion of three types of cells observed in the 
vaginal smear: epithelial cells, cornified cells and 
leukocytes [6]. 
Clomiphene citrate (CC) is a non-steroidal 
selective estrogen receptor modulator (SERM) of the 
triphenylethylene group that has become the most 
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widely prescribed drug for ovulation induction to 
reverse anovulation or oligo-ovulation [7]. It was 
described on the 19th WHO Model List of Essential 
Medicines [8], the most important medications needed 
in a basic health system.  
Clomiphene binds to the E2 receptors in the 
hypothalamus (interfering with recycling of receptors) 
to create a state of hypo-estrogenicity, thereby 
causing an enhanced gonadotropin-releasing 
hormone (GnRH) release followed by an increased 
secretion of gonadotropins which induces ovulation 
[9]. 
Ovulation is known to occur in 70% of cases, 
while pregnancy occurs only in about 25-30% of the 
cases. The low pregnancy rate is due to the 
antiestrogenic effects of CC on the cervix, which 
would make it difficult to sperm penetration and on the 
endometrial growth which would, therefore, be 
unreceptive to the embryo [10]. 
Some studies have suggested that 
clomiphene citrate if used for more than a year, may 
increase the risk of ovarian cancer [11]. 
This, however, is disputed, and some feel 
there is no significant increase in risk [12]. It is not 
recommended by the manufacturer to use clomiphene 
for more than 6 cycles [13]. 
The clinical effect of light can be classified as 
direct and indirect, depending on whether the light 
causes an effect to occur within the irradiated tissue 
or whether a nervous or neuroendocrine signal is 
generated in the irradiated area and causes a 
systemic effect in another part of the body [14]. 
 Low power lasers do not have a thermal 
effect on tissue. Photons may influence the 
proliferation of cells [15]. 
Low-level laser therapy (LLLT) is a form of 
laser medicine used in physical therapy and veterinary 
treatment that uses low-level lasers or light-emitting 
diodes to alter cellular function [16]. 
Photobiology works on the principle that, 
when the light hits certain molecules called 
chromophores, the photon energy causes electrons to 
be excited and jump from low-energy orbits to higher 
energy orbits. In nature, this stored energy can be 
used by the system to perform various cellular tasks, 
such as photosynthesis [17]. 
Cellular targets are mitochondria with the 
effect of increased adenosine triphosphate production, 
modulation of reactive oxygen species, and initiation 
of cellular signalling [18]. 
The final enzyme in the production of ATP by 
mitochondria, cytochrome-C-oxidase does appear to 
accept energy (photoacceptor) from laser-level lights, 
making it a possible candidate for mediating the 
properties of laser therapy [19]. 
The effects of LLLT appear to be limited to 
specified wavelengths of laser [20]. The typical 
wavelength is in the rage of 600-1000 nm (red to near 
infrared) [21]. 
Administering LLLT below the dose range 
does not appear to be effective [22] 
The depth of penetration of laser light 
depends on the light's wavelength, mode of the laser, 
power density, technical design of the apparatus and 
the treatment technique used [23]. 
 
 
Material and Methods 
 
All Institutional and National Guidelines for the 
care and use of experimental animals were followed. 
Eighty-two adult female-Wistar Albino rats 
(Rattus norvergicus) were used in this study since 
they are the most commonly used experimental 
animals and easily available, selected at the average 
fertile period at 10-15 weeks old and 180-220 gm 
body weight. 
The ovaries of two sacrificed female rats were 
subjected to diode laser 660 nm wavelength using an 
apparatus laser vex inc.-DPSSL II with contact 
control. The laser beam was delivered using a fibre-
optic that was introduced directly through the vagina.  
To estimate the accurate dose reaching the 
ovaries, a very sensitive power meter (Coherent-Laser 
Check = Model 1098293) was placed behind the 
ovaries to measure the amount of power delivered to 
the ovaries through the vaginal vault. 
Many measurements were done until we 
obtained the recommended power, in which at a 
current of 210 m AMP, the power at the tip of the 
fibre-optic was 9.06 mW and those reaching the 
ovaries was 5.03 mW, and this was the targeted 
power [24] [25] (Figure 1). 
 
Figure 1: Diode laser 660 nm-fibre out, curve (power mW& current 
mAMP) 
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Vaginal smears was then done every morning 
daily for at least three consecutive successive regular 
cycles, to gain experience in handling of rats and to 
be familiar with the technique and morphological 
features of each phase of estrous cycle and to 
determine the diestrus phase of the estrous cycle, in 
which ovulation induction-either by clomiphene citrate 
or by laser-should be conducted during this phase 
[26]. Only cyclic rats were used in this study, whereas 
rats with irregular cycles (Blocked) were excluded. 
Oestrous synchronisation was then 
performed, i.e. the stage of oestrous was determined 
by vaginal swab microscopically in each animal so 
that animals in the same oestrous stage were 
allocated to the same group. 
Determination of the phase of oestrous cycle 
was performed through a collection of vaginal 
secretions with a plastic pipette filled with 0.5-1 mL of 
normal saline (NaCl 0.9%) by inserting the tip into the 
vagina, but not deeply. Vaginal fluid was placed on 
glass slides. One drop was collected with a clean tip 
from each rat. This fresh drop was examined (either 
unstained or stained by methylene blue stain) under a 
light microscope, without the use of the condenser 
lens, with 10 and 40 x objective lenses. 
A pilot study was conducted using two rats 
administered clomiphene citrate, at a dose of 
20ug/day for 2 consecutive days, starting on the 
diestrus phase and then sacrificed on the 4
th
 day of 
the cycle. Serum samples for E2 and P were collected. 
Another pilot study was tried using three rats exposed 
to laser biostimulation at a dose of 150 mj/Cm
2
 (5 
MW/Cm
2
 x 30 sec) for two consecutive days. Starting 
in the diestrus phase and then sacrificed on the 4
th
 
day of the cycle, serum samples for E2 and P were 
collected. A 3
rd
 pilot study was done By exposing 
three rats to laser biostimulation at a dose of 150 
mj/Cm
2
, for three consecutive days (a cumulative 
dose of 450 mj/Cm
2
) [24] [25], results also recorded. 
Blood samples were collected by puncture of 
the ophthalmic venous plexus for E2 and P hormonal 
assay. 
Following these pilot studies (Eight rats were 
used in the pilot studies), the original study was 
started in January 2014 and continues to February 
2016, using a total number of 74 adult female rats. 
Two died (one from the laser group and one from the 
clomiphene group and were excluded from the study). 
The remaining 72 rats were divided into three groups. 
- Group I (Control Group): Consists of 17 rats 
used as a control group. Nothing was done for this 
group. 
- Group II (Clomid Group): Consists of 19 rats 
received clomiphene citrate 20 micrograms per rat 
daily orally-for 2 consecutive days, starting on the 
diestrus phase of the oestrous cycle [26]. 
- Group III (Laser Group): Consists of 36 rats 
in which their ovaries were exposed to diode laser 660 
nm wavelength (laser vex inc.-DPSSL II) with contact 
control (fiber-optic introduced through the vagina to 
reach the vault), using power density of 5 MW/Cm
2
, 
for 30 seconds (total dose of 150 mj/Cm
2
), for three 
consecutive days (a cumulative dose of 450 mj/Cm
2
). 
Starting in the diestrus phase of the oestrous cycle 
[24] [25]. 
At the end of the study, at metestrus phase 
(4
th
 day of starting induction), the phase in which 
serum Estradiol or progesterone begins to increase 
[27], blood samples were collected by puncture of the 
ophthalmic venous plexus & serum were stored at -
20ºC until assayed. 
The serum Estradiol and Progesterone assay 
were done by fully automated access system for 
immunoassay analysis using Electro-Chemi-
Luminescence (ECL) detection system. 
Data were statistically described regarding 
range, mean, standard deviation (± SD), and 
frequencies (number of cases). Comparison between 
the three study groups was made by one-way analysis 
of variance (ANOVA) test, and then analysis between 
every two groups was done by independent-samples 
t-test. All statistical calculations were done using 
computer programs, Microsoft Excel Office version 10 
(Microsoft Corporation, NY, USA) and SPSS 
(Statistical Package for the Social Science; SPSS inc., 
Chicago, IL, USA) for IBM version 22, statistical 
programs. 
A probability value (P value) less than 0.05 
was considered statistically significant. 
 
 
Results 
 
This study was conducted on 72 rats, divided 
into three groups: 17 rats control, 19 rats’ clomiphene 
& 36 rats’ laser group (Table 1). 
Table 1: Comparison between the three study groups as regard 
serum Estradiol level 
Estradiol (E2) 
(pg/ml) 
N Mean Std. 
Deviation 
Minimum Maximum F P 
Clomid Induction 19 32.211 15.0465 16.0 77.0 3.474 0.037 
Laser Induction 36 31.222 8.7541 15.0 57.0 
Control 17 24.000 6.8099 13.0 33.0 
Total 72 29.778 10.7824 13.0 77.0 
N: Number; F: ANOVA test; P: significance. 
 
There was the statistically significant 
difference between the three study groups regarding 
serum Estradiol (P = 0.037) (Table 2). 
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Table 2: Comparison between the three study groups as regard 
serum Progesterone level 
Progesterone 
(ng/ml) 
N Mean Std. 
Deviation 
Minimum Maximum F P 
Clomid Induction 19 30.977 12.2515 13.0 52.0 8.183 0.001 
Laser Induction 36 25.299 9.0915 12.0 51.4 
Control 17 18.353 5.2433 7.0 27.0 
Total 72 25.157 10.2544 7.0 52.0 
The cutoff the value of serum Progesterone in ovulation is 3.6ng/ml.  
 
There was the statistically significant 
difference between the three study groups regarding 
serum Progesterone (P = 0.001) (Table 3). 
Table 3: Comparison between laser & Clomid groups as regard 
serum Estradiol & serum progesterone levels 
 GROUP N Mean Std. 
Deviation 
Std. Error 
Mean 
t P 
Estradiol 
(E2) (pg/ml) 
Clomid 
Induction 
19 32.211 15.0465 3.4519 0.309 0.759 
Laser Induction 36 31.222 8.7541 1.4590 
Progesterone 
(ng/ml) 
Clomid 
Induction 
19 30.977 12.2515 2.8107 1.949 0.057 
Laser Induction 36 25.299 9.0915 1.5152 
N: Number; t: independent test; P: significance. 
 
There was no statistically significant 
difference between laser-treated group & Clomid 
induction group regarding serum Estradiol levels (P = 
0.759). 
 There was no statistically significant 
difference between laser-treated group & Clomid 
induction group regarding serum Progesterone levels 
(P = 0.057) (Table 4). 
Table 4: Pearson Correlation between serum Estradiol & serum 
Progesterone levels in control group 
GROUP = Control r 
Estradiol (E2) (pg/ml) Pearson Correlation 1.00 
N 17 
Progesterone (ng/ml) Pearson Correlation 0.585
*
 
P 0.014 
N 17 
 
There was a significant positive correlation 
between serum Estradiol & serum Progesterone 
levels in control group (P = 0.014) (Table 5). 
Table 5: Pearson Correlation between serum Estradiol & serum 
Progesterone levels in clomid group 
GROUP = Clomid Induction r 
Estradiol (E2) (pg/ml) Pearson Correlation 1.00 
N 19 
Progesterone (ng/ml) Pearson Correlation 0.579
**
 
P 0.009 
N 19 
 
There was a significant positive correlation 
between serum Estradiol & serum Progesterone 
levels in clomid group (P = 0.009) (Table 6). 
Table 6: Pearson Correlation between serum Estradiol & serum 
Progesterone levels in the laser group 
GROUP = Laser Induction r 
Estradiol (E2) (pg/ml) Pearson Correlation 1.00 
N 36 
Progesterone (ng/ml) Pearson Correlation 0.206 
P 0.228 
N 36 
Non-significant positive correlation was found 
between serum Estradiol & serum Progesterone 
levels in laser group (P = 0.228). 
 
 
Discussion 
 
This new modality of low power laser (LPL) 
biostimulation was compared with the conventional 
medical therapy using clomiphene citrate that 
depends on upregulation of hypothalamic-pituitary-
ovarian axis to induce ovulation, and with non-
interventional controls. 
The purpose of this study is to assess and 
compare the levels of serum Estradiol and serum 
Progesterone between the three studied groups, 
exactly at the same phase of the oestrous cycle 
(metestrus = diestrus 1) [27]. 
This is the 1st time that low power laser has 
been used as a biostimulant to normal (non PCO) 
ovaries and used to induce ovulation. 
 The only work done in this field, was carried 
out by two studies, the first study was conducted by 
Al-Watban and Andres [24], where they used He-Ne 
laser (632.8 nm) and solcoseryl in "in vitro" 
biostimulation on Chinese hamster ovary (CHO) and 
human skin fibroblast (HSF), using an optimum power 
density 1.25 mw/cm
2
 and cumulative doses of 60-600 
mj/cm
2
, with average 180 mj/cm
2
 given for three 
consecutive days, resulted in significant increase in 
cloning efficiency of CHO and HSF cells. 
The second work was carried out by Sherein 
and Hossam Eldein [25] who compared the effect of 
low power laser biostimulation with clomiphene citrate, 
in the induction of ovulation with non-interventional 
controls in female Wistar Albino rats with polycystic 
ovarian disease (PCO). In this study induction of 
polycystic ovaries was done by receiving oral letrozole 
0.5 mg/kg body weight-daily for 20 days in 60 rats. 
Rats were divided into three groups, 20 rats in each 
group. 
Clomid group received clomiphene citrate 20 
g/rat orally-daily for 2 consecutive days. 
Laser group received general anaesthesia, 
where their abdomen was opened, and their ovaries 
were exposed to diode laser 650 nm, using a dose of 
150 mj/cm
2
 (power density was 30 MW/cm
2
), using an 
apparatus - Intelite R 650-250, daily for 2 consecutive 
days. 
All animals then sacrificed on the 24th day 
from the 1st day of letrozole administration. Whole 
blood was collected for serum progesterone assay, 
and the ovaries were taken for histopathology. This 
study concluded that low power laser is a new 
encouraging method for induction of ovulation, and it 
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is more effective with less complication compared to 
clomid. 
Low power laser irradiation of cells at certain 
wavelengths can activate some of the native 
components resulting in alteration of specific 
biochemical reactions, as well as cell metabolism. 
This alteration forms the basis for low power laser 
effects [28]. 
The mitochondria are sensitive to irradiation 
with monochromatic visible and near-infrared light. It 
increases adenosine triphosphate synthesis and 
consumption of oxygen [29], as well as RNA and 
protein synthesis in the mitochondria [30]. 
In our study, we used diode laser 660nm 
wavelength, since its apparatus forms are small, 
portable&easily modulated. Also, the depth of 
penetration of diode laser is suitable to reach the 
human ovary. 
Using a fiber-optic, that was introduced 
directly through the vagina to deliver laser to the 
ovaries through the vaginal vault, reduces the number 
of animal loss (only one rat died in laser group) i.e. 
2.7% fatality, when compared to laparotomy and 
surgical mobilization of ovaries, to be directly exposed 
to laser beam and re-exposure on the 2nd day, this 
increases the animal loss to be six rats, i.e. 23% 
fatality, as done by Sherein and Hossam Eldein [25]. 
Mechanical manipulation of the ovary during laser 
application is not physiologic and may have a role in 
abnormal ovarian response, also using fibre optic can 
be suitable for application in women by introducing the 
fibre through an egg-pickup needle socket (used for in 
vitro fertilisation = IVF) under ultrasound guidance. 
Our study shows the statistically significant 
difference as regard serum Estradiol levels between 
the three studied groups (P value less than 0.05).  
The clomid induction group has higher serum 
Estradiol values (mean 32.21 ± SD 15.04), compared 
to the control group (mean 24 ± SD 6.81). 
This is in contrast with the study of Kilic-
Okman et al., [26] that was carried out to compare the 
effect of clomiphene citrate and letrozole on ovarian 
follicles, endometrium and hormone levels in rats. 
This study found no significant difference between 
clomiphene citrate treated rats and that given placebo 
as regard serum Estradiol (P value more than 0.05). 
The laser induction group has higher serum 
Estradiol levels (mean 31.22 ± SD 8.75), compared to 
the control group (mean 24 ± SD 6.81). 
 The mean serum Estradiol was not 
statistically significantly higher in the clomid group 
compared with laser group (P value more than 0.05). 
Also, this study shows the significant 
difference as regard serum progesterone levels 
between the three studied groups (P value less than 
0.05) statistically. 
 The clomid induction group has higher serum 
progesterone values (mean 30.97 ± SD 12.25), 
compared to the control group (mean 18.35 ± SD 
5.24). 
The result is in contrast with the study carried 
out by Sherein & Hossam Eldein [25], which found no 
significant difference between clomid and control 
groups as regard serum progesterone (P value more 
than 0.05)  
The laser induction group has higher serum 
progesterone levels (mean 25.29 ± SD 9.09), 
compared to the control group (mean 18.35 ± SD 
5.24). 
 This result is by Sherein&Hossam Eldein 
[25], who found the highly significant difference (P 
less than 0.001) in serum progesterone towards the 
laser-treated group. 
While in comparing serum progesterone 
levels between clomid and laser-treated group, the 
difference was found non-significant (p more than 
0.05), this is in contrast with Sherein & Hossam Eldein 
[25] who found statistically significant difference 
towards laser stimulated group (p less than 0.05). 
Significant positive correlation between serum 
Estradiol & serum progesterone levels was found in 
the control group (r = 0.585, P = 0.014). Significant 
positive correlation between serum Estradiol & serum 
progesterone levels was found in clomid treated group 
(r = 0.579, P = 0.009). Non-significant positive 
correlation between serum Estradiol & serum 
progesterone levels was found in the laser treated 
group (r = 0.206, P = 0.228). 
In conclusion, this study shows that ovarian 
laser biostimulation is a new encouraging method for 
induction of ovulation, at least in animals. This had 
been proven biochemically by a significant increase in 
serum Estradiol (that assess the endogenous 
estrogenic hormonal activity) and serum Progesterone 
(a good indicator for ovulation and corpus luteum 
function).  
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